Integrated Biopharma Inc financial data

Symbol
INBP on OTC
Industry
Pharmaceutical Preparations
Location
225 Long Avenue, Building 15, Hillside, NJ
State of incorporation
DE
Fiscal year end
June 30
Former names
INTEGRATED HEALTH TECHNOLOGIES INC (to 4/16/2003), CHEM INTERNATIONAL INC (to 5/14/2002)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 287 % -5.63%
Quick Ratio 184 % +0.28%
Debt-to-equity 37.8 % -28.7%
Return On Equity 2.26 %
Return On Assets 1.64 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.1M shares +0.5%
Common Stock, Shares, Outstanding 30.1M shares +0.12%
Entity Public Float 3.37M USD +3.34%
Common Stock, Value, Issued 60K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +0.45%
Weighted Average Number of Shares Outstanding, Diluted 30.6M shares +2.28%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) 795K USD +2108%
Nonoperating Income (Expense) 17K USD +200%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 818K USD +2053%
Income Tax Expense (Benefit) 388K USD +304%
Net Income (Loss) Attributable to Parent 430K USD
Earnings Per Share, Basic 0.01 USD/shares
Earnings Per Share, Diluted 0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.27M USD -12.5%
Accounts Receivable, after Allowance for Credit Loss, Current 4.39M USD +5.11%
Inventory, Net 11.2M USD +6.78%
Other Assets, Current 432K USD -10.4%
Assets, Current 18.3M USD +3.11%
Deferred Income Tax Assets, Net 4.4M USD -6.66%
Property, Plant and Equipment, Net 1.85M USD +13.3%
Operating Lease, Right-of-Use Asset 1.56M USD -37%
Assets 26.2M USD -1.72%
Accounts Payable, Current 2.76M USD -21.9%
Liabilities, Current 6.03M USD -2.71%
Operating Lease, Liability, Noncurrent 604K USD -61.3%
Liabilities 6.63M USD -14.5%
Retained Earnings (Accumulated Deficit) -32M USD +1.33%
Stockholders' Equity Attributable to Parent 19.6M USD +3.52%
Liabilities and Equity 26.2M USD -1.72%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 657K USD -50%
Net Cash Provided by (Used in) Financing Activities -7K USD -333%
Net Cash Provided by (Used in) Investing Activities -56K USD -47.4%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 30.1M shares +0.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 594K USD -53.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD +20%
Deferred Tax Assets, Valuation Allowance 1.27M USD -11.4%
Operating Lease, Liability 1.56M USD
Depreciation 330K USD -2.94%
Payments to Acquire Property, Plant, and Equipment 56K USD +47.4%
Lessee, Operating Lease, Liability, to be Paid 1.65M USD
Property, Plant and Equipment, Gross 9.87M USD +4.19%
Operating Lease, Liability, Current 954K USD +4.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 660K USD
Deferred Income Tax Expense (Benefit) 197K USD +2363%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 95K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 64K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.03M USD -1.43%
Deferred Federal Income Tax Expense (Benefit) 308K USD +211%
Operating Lease, Payments 236K USD -10.9%
Additional Paid in Capital 51.6M USD +0.46%
Depreciation, Depletion and Amortization 88K USD +14.3%
Share-based Payment Arrangement, Expense 49K USD -47.9%
Deferred State and Local Income Tax Expense (Benefit) 48K USD +671%
Interest Expense 52K USD 0%